Pfizer Announces a Fellowship Grant RFPInflammatory Bowel Disease
Competitive Grant Program – using expert review panelI.

BackgroundPfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives(e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet
medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) thatprovides detail regarding a specific area of interest, sets timelines for review and approval, and uses anexpert review panel (ERP). Institutions are invited to submit an application as outlined in the specificRFP.
This RFP reflects Pfizer’s commitment to advancing research, innovation, a n d training for medical,nursing, and allied health professionals.

32022
Inflammatory Bowel Disease Fellowship

II. Eligibility
Geographic Scope:

Europe, Canada, Australia, New Zealand, Japan, Israel and Turkey••

Applicant Eligibility
Criteria•••••Academic institutions that fall within the geographic scope of this RFP
Do not include the name or any identifying personal details of
the potential fellow(s) in application materials. This grant will beawarded to an institution, not an individual.
Institutions with fellowship programs that include independent research
and a strong mentoring program. Clinical training may be included in
the program but is not required.
No aspect of the fellowship program can benefit Pfizer’s businessor a Pfizer asset.
Examples of independent research include: observational studies
and outcomes research studies where the primary focus is thescientific understanding of disease; use of screening tools andtheir impact on improvement of patient health.
o Examples of research that would not be eligible include
research involving the study and/or evaluation of any
pharmaceutical product and basic science and/or fundamental
research (in animal model, in-vitro, etc.).
Examples of clinical training include: educational time with aninterdisciplinary team in review of case examples and relevant
didactic training as well as use of tools for improvement in patient
health for specific therapeutic areas or conditions.
Fellow time spent in the clinical setting that is supported throughgrant funds must not be billed as patient care.

III. Requirements
Date RFP Issued•

16 May 2022

Specific Area of Interestfor this RFP•

Inflammatory Bowel Disease (IBD). Through this grant programme, weintend to support research and clinical training fellowship programmes
in regions where there are continued workforce challenges in relation to
the management of IBD patients. Please note that the grant is notintended to support standard gastroenterology training periods but isintended to support supplementary IBD training for those who havealready completed a formal training programme in gastroenterology.

•As an equal opportunities employer Pfizer encourages applications frominstitutions who can demonstrate equitable distribution of fellowshipawards to applicants based on age, gender, nationality and ethnicity.
25% of this year’s fellowship grants will be awarded to institutions whoundertake to recruit their fellow from a developing nation*.

132022
Inflammatory Bowel Disease Fellowship•Grants will be awarded based on the strength of the requestingorganisation’s ability to provide training and guidance to the fellow.

•New IBD fellowship programmes are encouraged to apply. This grant
will not be awarded to the same institution on consecutive years.

*See Appendix 2 for full list of IMF emerging markets and developing nations (Page8-9)

Requirements for
Prospective Fellows:

Budget:Key Dates:•

Applying institution will be solely responsible for ensuring that any fellowthat will receive grant funds must have a legal right to participate in thefellowship in the country where the fellowship is taking place.

•Any applicable transparency law requirements must be satisfied withrespect to meals, payments and other transfers of value. As a conditionof the grant, the selected fellow will be named in transparency reporting
as a recipient of grant funding.

•Grant funding is available to support one fellow for up to a year at$70,000. The budget can only include salary and support of the fellow
benefits.

•Grant funds cannot be used for overhead or indirect costs.

•Funding will be awarded to the institution, not an individual.

•Fellow time spent in the clinical setting that is supported through grant
funds must not be billed as patient care.

•No aspect of the fellowship program budget can reflect a benefit toPfizer’s business or a Pfizer asset.

•RFP release date: 16 May 2022•

Full Proposal Deadline: 30 June 2022
Please note the deadline is 23:59 Eastern Time (New York, GMT -5).

•Review of Full Proposals by Expert Review Panel: August 2022•

Anticipated Full Proposal Notification Date: September 2022•

Grants distributed following execution of fully signed Letter ofAgreement•

Anticipated Project Start and End Dates: from October 2022, for 1 year232022
Inflammatory Bowel Disease Fellowship

How to Submit:•Please go to www.cybergrants.com/pfizer/GMGFellowship and sign in.
First-time users should click “Create new password”. [Note: there areindividual portals for each grant application type (e.g., fellowship, knowledge,LOI, research full proposal, and QI full proposal). Please be sure to use theURL above.]

Questions:

Review and Approval
Process

Mechanism by which
Applicants will beNotified:••

Click the “Start A New Fellowship Application” button.
Select the following Competitive Grant Program Name: [2022 I&I G:
IDM IBD Fellowship]•Requirements for submission:• Complete all required sections of the online application•

Upload Proposal (see Appendix).

•Upload Budget file.

•If you encounter any technical difficulties with the website, please click
the “Technical Questions” link at the bottom of the page.

•If you have questions regarding this RFP, please direct them in writing
to the Grant Officer, Ai Ping Lee (AiPing.Lee@pfizer.com), with thesubject line 2022 I&I G: IDM IBD Fellowship, May 2022.

•A specific grant program RFP uses an expert review panel (ERP) tomake final grant decisions.
The panels are comprised of professionals from the medical community
with advanced degrees and expertise in particular clinical areas, orspeciﬁc needs of a geographic region/learner group, or expertise inresearch, continuing professional development or quality improvement•••

All applicants will be notified via email by the dates noted above.
Applicants may be asked for additional clarification during the review
period.

3

32022
Inflammatory Bowel Disease Fellowship

Appendix A
Proposal Requirements
The proposal should be submitted in Word or a PDF. This document should be formatted with single-spaced
using 12-point font and 1-inch margins and should not exceed 10-15 pages.

••

Title: Please include the fellowship title, and main institutions
Abstract: Please include an abstract summary of your proposal including
the goal of the fellowship, methods the institution uses to support thefellow’s training and research, and assessment.

Overall Goals andObjectives of theFellowship••

Describe the overall goal of the fellowship.
Describe the focus of research and/or clinical training as applicable thatis being supported in general terms based on the categorizations listed
in this application.

Methods••

Please describe the mentoring process.
Include a description of the methods used to support the fellow and theirresearch and/or clinical training.

Resources•

Please describe the institution’s academic, clinical training, and research
capacity.
Describe the facilities/resources that are made available to the fellow.
Provide a summary of relevant past work that is applicable.

Cover Page
(not to exceed 1 page)••

Challenges•

Please provide a summary of potential challenges and of plans foraddressing those challenges

Institutional Support••

Division Head/ Department Chair Letter of Support.
Primary mentor; Secondary mentor (if applicable) Letter of Support•

Budget: Address any additional sources of financial support forthis proposal, including current and pending sources of funding•

Any request for funds beyond salary support will not be provided as partof the award•

Provide an anticipated timeline for your project including project start/enddates

BudgetAnticipated ProjectTimeline4

32022
Inflammatory Bowel Disease Fellowship

Additional Information•

If there is any additional information you feel Pfizer should be aware ofconcerning the importance of this project, please summarize here

Budget Requirements
The budget should be submitted in Excel. There is no page limit.

532022
Inflammatory Bowel Disease Fellowship

Appendix B
Emerging markets and developing nations (IMF 20201)
Emerging and Developing Asia
BhutanBrunei Darussalam
Cambodia
China
FijiIndia
Indonesia
Kiribati
Lao P.D.R.
Malaysia
Maldives
Marshall Islands
Micronesia
Mongolia
Myanmar
Nauru
Nepal
Palau
Papua New Guinea
Philippines
Samoa
Solomon Islands
Sri Lanka
Thailand
Timor-Leste
Tonga
TuvaluVanuatu
Vietnam
Emerging and Developing Europe
Albania
BelarusBosnia and HerzegovinaBulgaria
Croatia
Hungary
KosovoMoldova
Montenegro
North Macedonia
PolandRomania
RussiaSerbiaTurkeyUkraine
Latin America and the Caribbean
Antigua and Barbuda
Argentina
Aruba
The Bahamas
Barbados
BelizeBolivia
BrazilChile
Colombia
Costa Rica
Dominica
Dominican Republic
EcuadorEl Salvador
GrenadaGuatemala
GuyanaHaiti
Honduras
Jamaica
MexicoNicaragua
PanamaParaguay
Peru
St. Kitts and Nevis
St. Lucia

6

St. Vincent and the Grenadines
Suriname
Trinidad and Tobago
Uruguay
Venezuela
Middle East and Central Asia
Afghanistan
Algeria
Armenia
Azerbaijan
BahrainDjiboutiEgypt
Georgia
Iran
Iraq
JordanKazakhstan
KuwaitKyrgyz Republic
Lebanon
Libya
Mauritania
MoroccoOman
Pakistan
Qatar
Saudi Arabia
Somalia
Sudan
Syria
Tajikistan
Tunisia
Turkmenistan
United Arab Emirates
Uzbekistan
Yemen

32022
Inflammatory Bowel Disease Fellowship

Sub-Saharan Africa
AngolaBenin
Botswana
Burkina Faso
BurundiCabo Verde
Cameroon
Central African Republic
ChadComoros
Democratic Republic of the Congo
Sub-Saharan Africa (Cont’d)
Republic of Congo
Côte d’Ivoire
Equatorial Guinea

Namibia
Niger
Nigeria
RwandaSão Tomé and Príncipe
SenegalSeychelles
Sierra Leone
South Africa
South Sudan
Tanzania
Togo
UgandaZambiaZimbabwe

Eritrea
Eswatini
Ethiopia
Gabon
The Gambia
Ghana
GuineaGuinea-Bissau
Kenya
LesothoLiberia
Madagascar
MalawiMali
Mauritius
Mozambique

1. World Economic Outlook 2020. IMF. Downloaded from:https://www.imf.org/en/Publications/WEO/weo-database/2020/October/select-aggr-data
On 25 January 2021

7